These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22541039)

  • 1. Vocal acoustic biomarkers of depression severity and treatment response.
    Mundt JC; Vogel AP; Feltner DE; Lenderking WR
    Biol Psychiatry; 2012 Oct; 72(7):580-7. PubMed ID: 22541039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    ; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
    JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections of depression in acoustic measures of the patient's speech.
    Alpert M; Pouget ER; Silva RR
    J Affect Disord; 2001 Sep; 66(1):59-69. PubMed ID: 11532533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
    Kuchibhatla MN; Fillenbaum GG
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):483-94. PubMed ID: 22035643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
    Blumenthal JA; Sherwood A; Rogers SD; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; O'Connell C; Johnson JJ; Patidar SM; Waugh R; Hinderliter A
    Clin Trials; 2007; 4(5):548-59. PubMed ID: 17942470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
    Jiang W; O'Connor C; Silva SG; Kuchibhatla M; Cuffe MS; Callwood DD; Zakhary B; Henke E; Arias RM; Krishnan R;
    Am Heart J; 2008 Sep; 156(3):437-44. PubMed ID: 18760123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.
    Taraz M; Khatami MR; Dashti-Khavidaki S; Akhonzadeh S; Noorbala AA; Ghaeli P; Taraz S
    Int Immunopharmacol; 2013 Nov; 17(3):917-23. PubMed ID: 24121064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
    Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH
    J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.
    Webb CA; Trivedi MH; Cohen ZD; Dillon DG; Fournier JC; Goer F; Fava M; McGrath PJ; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Huys Q; Bruder G; Kurian BT; Jha M; DeRubeis RJ; Pizzagalli DA
    Psychol Med; 2019 May; 49(7):1118-1127. PubMed ID: 29962359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
    Trombello JM; Killian MO; Grannemann BD; Rush AJ; Mayes TL; Parsey RV; McInnis M; Jha MK; Ali A; McGrath PJ; Adams P; Oquendo MA; Weissman MM; Carmody TJ; Trivedi MH
    J Psychopharmacol; 2019 Feb; 33(2):185-193. PubMed ID: 30652941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance study for adolescent depression.
    Cheung A; Kusumakar V; Kutcher S; Dubo E; Garland J; Weiss M; Kiss A; Levitt A
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):389-94. PubMed ID: 18759650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.